tirofiban should generally not be interrupted during procedures unless there is a specific physician order.
High Alert Drug: glycoprotein IIb/IIIa inhibitors (e.g Aggrastat)
• Electronic order sets available for ordering. • Bleeding Precautions sign hung in Critical Care and on Telemetry. • Physician/Pharmacist independently verify calculation of dose prior to administration. • Two RNs independently verify dosage prior to administration.
Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
tirofiban (Aggrastat) IV Infusion Key: order set
Y
Y
N
N
N
N
N
N
Anticoagulant / Antiplatelet Stoppage For Procedures
generic (Brand)
Dept.
Procedure Type (hover over entry for examples)
Stop Medication Prior To Procedure Restart after:
tirofiban (Aggrastat)
Anesthesia
High-risk
8-24 hours Restart after 8-12 hours
Intermediate-risk
8-24 hours Restart after 8-12 hours
Low-risk
8-24 hours Restart after 8-12 hours
Patients with high risk of bleeding (eg, old age, history of bleeding tendency, concurrent uses of other anticoagulants/antiplatelets, liver cirrhosis or advanced liver disease, and advanced renal disease) undergoing low- or intermediate-risk procedures should be treated as intermediate or high risk, respectively.
• Bleeding Precautions sign hung in Critical Care and on Telemetry.
• Physician/Pharmacist independently verify calculation of dose prior to administration.
• Two RNs independently verify dosage prior to administration.
(KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
IV Infusion Key: order set
(hover over entry for examples)
(Aggrastat)